Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00206830 · ClinicalTrials.gov registry record · Phase 2
SHORTness of Breath In the Emergency Department (SHORTIE)
A Phase 2 study, sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- Phase 2
- Development phase
- 306
- Enrollment target
NCT00206830 is a Phase 2 study that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 306 participants.
The verdict
NCT00206830, a Phase 2 study, has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 306 participants
- Enrollment target
Study Summary
SHORTIE is a two-phase study to determine the impact of the Triage Profiler S.O.B. (Shortness Of Breath) Panel on patient management, outcome, and cost.
Interventions
- DEVICE Triage Profiler S.O.B. Panel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2005-04 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00206830
The ClinicalTrials.gov registry entry for NCT00206830 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott RDx Cardiometabolic, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Triage Profiler S.O.B. Panel is the first listed.
NCT00206830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00206830 about?
NCT00206830 is a clinical study titled "SHORTness of Breath In the Emergency Department (SHORTIE)". SHORTIE is a two-phase study to determine the impact of the Triage Profiler S.O.B. (Shortness Of Breath) Panel on patient management, outcome, and cost.
What is the current status of trial NCT00206830?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 306 participants. The study started on 2005-04. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00206830?
The interventions under investigation include: Triage Profiler S.O.B. Panel (DEVICE).
Who is sponsoring clinical trial NCT00206830?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.